EU could pay over $10 billion for Pfizer, CureVac vaccines

The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-Bio-NTech and CureVac, an EU official involved in the talks told Reuters.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2IZmykV
via IFTTT